Disulfiramlike Mushroom Toxicity Differential Diagnoses

1. Kang Y, Kim H, Choi HT. Biochemical characterization of chitinase 2 expressed during the autolytic phase of the inky cap, Coprinellus congregatus. J Microbiol. 2013 Apr. 51(2):189-93. [Medline].

2. Malcolm R, Olive MF, Lechner W. The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf. 2008 Jul. 7(4):459-72. [Medline].

3. Garbutt JC. The state of pharmacotherapy for the treatment of alcohol dependence. J Subst Abuse Treat. 2009 Jan. 36(1):S15-23; quiz S24-5. [Medline].

4. Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014 Dec. 52(10):1032-283. [Medline]. [Full Text].

5. Tayyareci Y, Acarel E. Acute myocardial infarction associated with disulfiram-alcohol interaction in a young man with normal coronary arteries. Turk Kardiyol Dern Ars. 2009. 37(1):48-50. [Medline].

6. Banys P. The clinical use of disulfiram (Antabuse): a review. J Psychoactive Drugs. 1988 Jul-Sep. 20(3):243-61. [Medline].

7. Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. 2005 Feb. 28(2):175-83. [Medline].

8. Brent J, McMartin K, Phillips S, Aaron C, Kulig K; Methylpyrazole for Toxic Alcohols Study Group. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001 Feb. 344(6):424-9. [Medline].

9. Carlsson A, Henning M, Lindberg P, Martinson P, Trolin G, Waldeck B, et al. On the disulfiram-like effect of coprine, the pharmacologically active principle of Coprinus atramentarius. Acta Pharmacol Toxicol (Copenh). 1978 Apr. 42(4):292-7. [Medline].

10. Christensen JK, Moller IW, Ronsted P, Angelo HR, Johansson B. Dose-effect relationship of disulfiram in human volunteers. I: Clinical studies. Pharmacol Toxicol. 1991 Mar. 68(3):163-5. [Medline].

11. Hender E, May T, Beulke S. Poisoning due to eating fungi in Victoria. Aust Fam Physician. 2000 Oct. 29(10):1000-4. [Medline].

12. Ho MP, Yo CH, Liu CM, Chen CL, Lee CC. Refractive hypotension in a patient with disulfiram-ethanol reaction. Am J Med Sci. 2007 Jan. 333(1):53-5. [Medline].

13. Kunkel DB, Connor DA. Coprine-containing mushrooms. Spoerke DG, Rumack BH. Handbook of Mushroom Poisoning: Diagnosis and Treatment. CRC Press, LLC; 1994. 303-7.

14. Meyer JH, Herlocher JE, Parisian J. Esophageal rupture after mushroom-alcohol ingestion. N Engl J Med. 1971 Dec 2. 285(23):1323. [Medline].

15. Michelot D. Poisoning by Coprinus atramentarius. Nat Toxins. 1992. 1(2):73-80. [Medline].

16. Miller NS, Goodwin DW, Jones FC, Gabrielli WF, Pardo MP, Anand MM, et al. Antihistamine blockade of alcohol-induced flushing in orientals. J Stud Alcohol. 1988 Jan. 49(1):16-20. [Medline].

17. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP. The status of disulfiram: a half of a century later. J Clin Psychopharmacol. 2006 Jun. 26(3):290-302. [Medline].

18. Wright C, Moore RD. Disulfiram treatment of alcoholism. Am J Med. 1990 Jun. 88(6):647-55. [Medline].

19. Yilmaz A, Gursoy S, Varol O, Nur N, Ozyilkan E. Emergency room cases of mushroom poisoning. Saudi Med J. 2006 Jun. 27(6):858-61. [Medline].

C Crawford Mechem, MD, MS, FACEP Professor, Department of Emergency Medicine, University of Pennsylvania School of Medicine; Emergency Medical Services Medical Director, Philadelphia Fire Department

C Crawford Mechem, MD, MS, FACEP is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

Asim Tarabar, MD Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

B Zane Horowitz, MD, FACMT Professor, Department of Emergency Medicine, Oregon Health and Sciences University School of Medicine; Medical Director, Oregon Poison Center; Medical Director, Alaska Poison Control System

B Zane Horowitz, MD, FACMT is a member of the following medical societies: American College of Medical Toxicology

Disclosure: Nothing to disclose.

Michael Hodgman, MD Assistant Clinical Professor of Medicine, Department of Emergency Medicine, Bassett Healthcare

Michael Hodgman, MD is a member of the following medical societies: American College of Medical Toxicology, American College of Physicians, Medical Society of the State of New York, and Wilderness Medical Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of